OAT-4828 is an orally active ubiquitin-specific protease 7 (USP7) inhibitor with an IC50 of 32 nM. OAT-4828 induces antileukemic activity in B-cell-derived non-Hodgkins lymphoma models via inhibition of USP7. OAT-4828 is applicable to research related to chronic lymphocytic leukemia[1].
Molecular Weight:
571.61
CAS Number:
[2947497-65-4]
Formula:
C28H28F3N5O3S
Target:
Deubiquitinase
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted